Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
6TX8
DownloadVisualize
BU of 6tx8 by Molmil
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH IMIDAZOLE
Descriptor: CHLORIDE ION, IMIDAZOLE, Peptidyl-prolyl cis-trans isomerase FKBP5, ...
Authors:Fiegen, D, Draxler, S.W.
Deposit date:2020-01-13
Release date:2020-05-27
Last modified:2024-01-24
Method:X-RAY DIFFRACTION (1.2 Å)
Cite:Hybrid Screening Approach for Very Small Fragments: X-ray and Computational Screening on FKBP51.
J.Med.Chem., 63, 2020
6TX6
DownloadVisualize
BU of 6tx6 by Molmil
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH NICOTINAMIDE
Descriptor: CHLORIDE ION, NICOTINAMIDE, Peptidyl-prolyl cis-trans isomerase FKBP5, ...
Authors:Fiegen, D, Draxler, S.W.
Deposit date:2020-01-13
Release date:2020-05-27
Last modified:2024-01-24
Method:X-RAY DIFFRACTION (0.98 Å)
Cite:Hybrid Screening Approach for Very Small Fragments: X-ray and Computational Screening on FKBP51.
J.Med.Chem., 63, 2020
6TXX
DownloadVisualize
BU of 6txx by Molmil
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH SAFit2
Descriptor: (1R)-3-(3,4-dimethoxyphenyl)-1-{3-[2-(morpholin-4-yl)ethoxy]phenyl}propyl (2S)-1-[(2S)-2-[(1S)-cyclohex-2-en-1-yl]-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carboxylate, Peptidyl-prolyl cis-trans isomerase FKBP5
Authors:Fiegen, D, Draxler, S.W.
Deposit date:2020-01-14
Release date:2020-05-27
Last modified:2024-01-24
Method:X-RAY DIFFRACTION (2.1 Å)
Cite:Hybrid Screening Approach for Very Small Fragments: X-ray and Computational Screening on FKBP51.
J.Med.Chem., 63, 2020
4YHL
DownloadVisualize
BU of 4yhl by Molmil
Reversal Agent for Dabigatran
Descriptor: aDabi-Fab2b heavy chain, aDabi-Fab2b light chain
Authors:Schiele, F, Nar, H.
Deposit date:2015-02-27
Release date:2016-01-13
Last modified:2024-10-23
Method:X-RAY DIFFRACTION (2.09 Å)
Cite:Structure-guided residence time optimization of a dabigatran reversal agent.
Mabs, 7, 2015
4YHI
DownloadVisualize
BU of 4yhi by Molmil
Reversal Agent for Dabigatran
Descriptor: N-[(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alanine, aDabi-Fab2a heavy chain, aDabi-Fab2a light chain
Authors:Schiele, F, Nar, H.
Deposit date:2015-02-27
Release date:2016-01-13
Last modified:2024-11-06
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Structure-guided residence time optimization of a dabigatran reversal agent.
Mabs, 7, 2015
4YHM
DownloadVisualize
BU of 4yhm by Molmil
Reversal Agent for Dabigatran
Descriptor: N-[(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alanine, aDabi-Fab2b heavy chain, aDabi-Fab2b light chain
Authors:Schiele, F, Nar, H.
Deposit date:2015-02-27
Release date:2016-01-13
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (2.16 Å)
Cite:Structure-guided residence time optimization of a dabigatran reversal agent.
Mabs, 7, 2015
4YGV
DownloadVisualize
BU of 4ygv by Molmil
Reversal Agent for Dabigatran
Descriptor: GLYCEROL, aDabi-Fab2a heavy chain, aDabi-Fab2a light chain
Authors:Schiele, F, Nar, H.
Deposit date:2015-02-26
Release date:2015-06-17
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (1.76 Å)
Cite:Structure-guided residence time optimization of a dabigatran reversal agent.
Mabs, 7, 2015
4YHK
DownloadVisualize
BU of 4yhk by Molmil
Reversal Agent for Dabigatran
Descriptor: GLYCEROL, N-[(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alanine, aDabi-Fab2a heavy chain, ...
Authors:Schiele, F, Nar, H.
Deposit date:2015-02-27
Release date:2016-01-13
Last modified:2024-10-16
Method:X-RAY DIFFRACTION (2.21 Å)
Cite:Structure-guided residence time optimization of a dabigatran reversal agent.
Mabs, 7, 2015
4YHN
DownloadVisualize
BU of 4yhn by Molmil
Dabigatran Reversal Agent
Descriptor: aDabi-Fab3 heavy chain, aDabi-Fab3 light chain
Authors:Schiele, F, Nar, H.
Deposit date:2015-02-27
Release date:2016-02-10
Last modified:2024-10-23
Method:X-RAY DIFFRACTION (2.31 Å)
Cite:Structure-guided residence time optimization of a dabigatran reversal agent.
Mabs, 7, 2015
4YHO
DownloadVisualize
BU of 4yho by Molmil
Reversal Agent for Dabigatran
Descriptor: N-[(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alanine, aDabi-Fab3 heavy chain, aDabi-Fab3 light chain
Authors:Schiele, F, Nar, H.
Deposit date:2015-02-27
Release date:2016-01-13
Last modified:2024-10-16
Method:X-RAY DIFFRACTION (1.82 Å)
Cite:Structure-guided residence time optimization of a dabigatran reversal agent.
Mabs, 7, 2015
2WFJ
DownloadVisualize
BU of 2wfj by Molmil
Atomic resolution crystal structure of the PPIase domain of human cyclophilin G in complex with cyclosporin A.
Descriptor: 1,2-ETHANEDIOL, CHLORIDE ION, CYCLOSPORIN A, ...
Authors:Stegmann, C.M, Sheldrick, G.M, Wahl, M.C.
Deposit date:2009-04-06
Release date:2009-06-16
Last modified:2019-05-22
Method:X-RAY DIFFRACTION (0.75 Å)
Cite:The Thermodynamic Influence of Trapped Water Molecules on a Protein-Ligand Interaction.
Angew.Chem.Int.Ed.Engl., 48, 2009
2WFI
DownloadVisualize
BU of 2wfi by Molmil
Atomic resolution crystal structure of the PPIase domain of human cyclophilin G
Descriptor: MAGNESIUM ION, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE G
Authors:Stegmann, C.M, Sheldrick, G.M, Wahl, M.C.
Deposit date:2009-04-06
Release date:2009-06-16
Last modified:2019-05-22
Method:X-RAY DIFFRACTION (0.75 Å)
Cite:The Thermodynamic Influence of Trapped Water Molecules on a Protein-Ligand Interaction
Angew.Chem.Int.Ed.Engl., 48, 2009
4EOW
DownloadVisualize
BU of 4eow by Molmil
Crystal structure of a disease-associated anti-human GM-CSF autoantibody MB007
Descriptor: MB007 IgG1 Fab fragment light chain, MB007 human IgG1 Fab fragment heavy chain
Authors:Blech, M.
Deposit date:2012-04-16
Release date:2012-08-22
Last modified:2024-10-09
Method:X-RAY DIFFRACTION (1.97 Å)
Cite:Molecular structure of human GM-CSF in complex with a disease-associated anti-human GM-CSF autoantibody and its potential biological implications.
Biochem.J., 447, 2012
<12

 

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon